Back

Purified CBD and CBD-rich full-spectrum Cannabis sativa extract potentiate the angiogenic paracrine function of umbilical cord derived mesenchymal stem cells

Fontecilla-Escobar, J.; Flores-Montero, K.; Buzza, H. H.; Acuna Astudillo, R.; Hernandez, I.; Bellomo Perazza, A. I.; Elhalem, E.; Bigatti, G.; Croci, D. O.; Ezquer, M.; Ruete, M. C.

2026-07-09 cell biology
10.64898/2026.07.04.736503 bioRxiv
Show abstract

Background: Chronic and non-healing wounds remain a major clinical challenge with limited therapeutic options. Angiogenesis and inflammation are central to tissue repair, and mesenchymal stem cells (MSC) contribute to these processes through their trophic and immunomodulatory secretome. Cannabidiol (CBD) exhibits antioxidant and immunomodulatory properties. However, whether CBD-rich Cannabis sativa extract stimulate MSC toward a pro-angiogenic secretome remains unclear. Purpose: This study aims to determine whether purified CBD or a phytochemically CBD-rich full spectrum extract stimulate umbilical cord-derived human MSC (UC-hMSC) to secrete pro-angiogenic factors and enhance endothelial responses relevant to wound healing. Methods: UC-hMSC were preconditioned with either purified CBD or a CBD-rich full-spectrum extract. Transcriptional changes were assessed by qPCR. The functional impact of the resulting secretome was evaluated in vitro using HUVEC-based proliferation and tube formation assays, and in vivo through the chick chorioallantoic membrane assay. To explore underlying mechanisms, we examined HIF-1 stabilization and VEGFA release in UC-hMSC, and VEGFR-2/ERK signaling in HUVEC. Results: Purified CBD and full-spectrum CBD extract preconditioned UC-hMSC secretomes, increased HUVEC proliferation, tube formation, and enhanced vascular branching in the CAM assay. Mechanistic analyses indicated activation of the HIF-1/VEGF axis in UC-hMSC, and ERK1/2 activation in HUVEC that was sensitive to VEGFR-2 blockade. Conclusion: Purified CBD and CBD-rich full-spectrum extract prime UC-hMSC toward a pro-angiogenic secretome that promotes endothelial activation and neovascularization. These findings suggest that cannabinoid-based preconditioning of UC-hMSC involves the HIF-1/VEGF axis and VEGFR-2/ERK signaling pathways in endothelial cells, supporting further investigation of this approach in wound healing and regenerative therapies.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 13%
13.7%
2
Scientific Reports
3612 papers in training set
Top 14%
5.9%
3
Stem Cells
31 papers in training set
Top 0.1%
5.9%
4
Cell Death & Disease
21 papers in training set
Top 0.1%
4.6%
5
Life Sciences
27 papers in training set
Top 0.1%
4.3%
6
Cells
249 papers in training set
Top 0.8%
3.4%
7
Stem Cell Research & Therapy
30 papers in training set
Top 0.2%
2.8%
8
Pharmaceutics
24 papers in training set
Top 0.2%
2.6%
9
International Journal of Molecular Sciences
494 papers in training set
Top 5%
2.5%
10
Pharmaceuticals
34 papers in training set
Top 0.3%
2.3%
11
Stem Cells Translational Medicine
13 papers in training set
Top 0.1%
2.3%
50% of probability mass above
12
The FASEB Journal
194 papers in training set
Top 2%
2.0%
13
Biomolecules
100 papers in training set
Top 0.8%
2.0%
14
Frontiers in Nutrition
24 papers in training set
Top 0.5%
1.4%
15
Medical Research Archives
11 papers in training set
Top 0.2%
1.2%
16
Brain Research
38 papers in training set
Top 0.4%
1.2%
17
Journal of Translational Medicine
57 papers in training set
Top 1%
1.1%
18
Experimental Cell Research
28 papers in training set
Top 0.4%
1.1%
19
Cell Communication and Signaling
51 papers in training set
Top 0.9%
1.1%
20
Bioscience Reports
27 papers in training set
Top 1%
1.1%
21
Biochemical and Biophysical Research Communications
84 papers in training set
Top 2%
1.1%
22
International Journal of Biological Macromolecules
76 papers in training set
Top 2%
1.1%
23
Journal of Molecular Cell Biology
22 papers in training set
Top 0.2%
1.0%
24
iScience
1154 papers in training set
Top 31%
1.0%
25
Frontiers in Cardiovascular Medicine
53 papers in training set
Top 2%
1.0%
26
Frontiers in Pharmacology
111 papers in training set
Top 3%
0.9%
27
Frontiers in Cellular Neuroscience
91 papers in training set
Top 2%
0.9%
28
Immunity, Inflammation and Disease
10 papers in training set
Top 0.3%
0.9%
29
Journal of Thrombosis and Haemostasis
32 papers in training set
Top 0.4%
0.9%
30
eLife
5828 papers in training set
Top 67%
0.6%